A previous report using tissue microarray analysis revealed decreased expression of Regulator of G-protein signaling 16 (RGS16) in pancreatic tumors with lymph-node metastases compared to nonmetastasized pancreatic cancer and this loss was associated with decreased patient survival [26]. Here, RGS16 is linked to pancreatic neoplasm.